Get a glimpse into our company and investor data—powered by the PitchBook Platform
A portfolio of 25 U.S. FDA-approved abbreviated new drug applications. The portfolio includes ntecavir, an antiviral medication used in the treatment of hepatitis B viral infection (HBV).
This information is reserved for PitchBook Platform users. To explore Sandoz (Portfolio of 25 ANDAs)‘s full profile, request access.
© 2019 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.